Zac Jiwa, a federal Medicare official, delivered a eulogy of sorts at a Thursday Medicare event highlighting the successes of ...

CAR-T therapy is toting up more remissions in autoimmune disease, and generating a flood of experimentation and investment.

The panel had become a flashpoint as RFK Jr.'s health department worked to limit the number of recommended childhood shots.

In December, Trump said he would summon health insurance execs to the White House. It doesn't seem a meeting ever happened.

Why is old exon science getting new traction? What’s unsettling biotech VCs? And who will be the next CEO of PhRMA?

For decades, venture capitalists have relied on a tried-and-true recipe to make money in biotech. Now that approach is being ...

A smart contact lens described in a research paper on Wednesday combines therapeutic and diagnostic capabilities for glaucoma ...

We can’t afford another sweeping restructuring of the food supply based on imprecise interventions and uncertain science,” ...

MAHA ELEVATE could open a federal funding pipeline to interventions that can't survive contact with a plausibility filter.

FDA rejects a proposal to deregulate certain types of AI devices, pharma invests $50 million in DTx, and more.

Steve Ubl, chief executive of PhRMA, plans to step down at the end of the ‌year, after more than a decade leading the main ...

Chatterjee is a professor of economic development, innovation, and global health economy at the University of Sussex and an ...